Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
5.82
-0.61 (-9.49%)
At close: May 29, 2026, 4:00 PM EDT
5.84
+0.02 (0.34%)
After-hours: May 29, 2026, 7:46 PM EDT

Plus Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4071781116
Market Cap Growth
343.74%947.72%-14.33%-26.39%-33.33%67.05%
Enterprise Value
32.1558.696.5-0.64-3.583
Last Close Price
5.8212.8128.7543.75120.00393.75
PS Ratio
7.6613.631.161.6148.00-
PB Ratio
8.0817.78-0.76---
P/TBV Ratio
3.139.98-0.99---
EV/Sales Ratio
6.1711.261.12-0.13-15.99-
EV/EBITDA Ratio
---0.050.19-
EV/EBIT Ratio
---0.050.18-
EV/FCF Ratio
---0.050.28-
Debt / Equity Ratio
0.060.19-0.37---
Net Debt / Equity Ratio
-1.20-3.080.03---
Net Debt / EBITDA Ratio
0.780.830.020.350.660.97
Net Debt / FCF Ratio
0.660.590.020.350.970.88
Asset Turnover
0.290.450.650.280.010
Quick Ratio
2.071.090.270.801.533.13
Current Ratio
2.271.230.340.921.843.36
Return on Equity (ROE)
-137.51%903.94%290.04%---
Return on Assets (ROA)
-104.20%-133.27%-163.09%-75.57%-85.99%-72.91%
Return on Invested Capital (ROIC)
929.18%278.91%243.74%325.54%795.32%-2242.96%
Return on Capital Employed (ROCE)
-236.43%623.52%355.94%-210.18%-140.17%-126.30%
Buyback Yield / Dilution
-1939.26%-910.35%-145.18%-79.45%-117.18%-173.03%
Total Shareholder Return
-1939.26%-910.35%-145.18%-79.45%-117.18%-173.03%
SEC Filings: 10-K · 10-Q